Antibodies to MOG in CSF only: pathological findings support the diagnostic value
- 20 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Acta Neuropathologica
- Vol. 141 (5), 801-804
- https://doi.org/10.1007/s00401-021-02286-3
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological studyBrain, 2020
- Unilateral Leptomeningeal Enhancement in Myelin Oligodendrocyte Glycoprotein Immunoglobulin G–Associated DiseaseJAMA Neurology, 2020
- The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibodyActa Neuropathologica, 2020
- Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative casesNeurology, 2019
- Myelin oligodendrocyte glycoprotein antibodies in neurological diseaseNature Reviews Neurology, 2019
- Fulminant demyelinating encephalomyelitisNeurology Neuroimmunology & Neuroinflammation, 2015